IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a recombinant analog of human IGF-1 with an 83-amino-acid sequence and an N-terminal extension that extends its half-life to approximately 2030 hours compared to endogenous IGF-1's 10-minute half-life
Still following
These results are consistent with Tateishi et al
Ipamorelin appears to ease that brake during a short window
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al
Quite different in form but also falling within the NPI category are neuromodulation proceduresboth invasive and noninvasiveincluding deep brain stimulation, transcranial pulse stimulation, repetitive transcranial magnetic stimulation, and ultrasound (Leinenga et al., 2024)